Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 USD | +3.45% | -25.00% | -87.85% |
Mar. 15 | Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs | MT |
Mar. 12 | News Highlights : Top Company News of the Day - Tuesday at 5 AM ET | DJ |
Financials (USD)
Sales 2021 | 52.9M | Sales 2022 | 62.84M | Capitalization | 411M |
---|---|---|---|---|---|
Net income 2021 | -428M | Net income 2022 | -573M | EV / Sales 2021 | 29.1 x |
Net Debt 2021 | 111M | Net Debt 2022 | 84.53M | EV / Sales 2022 | 7.89 x |
P/E ratio 2021 |
-3.2
x | P/E ratio 2022 |
-0.65
x | Employees | 949 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 97.77% |
1 day | +5.84% | ||
1 week | -3.33% | ||
Current month | +81.25% | ||
1 month | +81.25% | ||
3 months | -42.00% | ||
6 months | -82.74% | ||
Current year | -88.26% |
Managers | Title | Age | Since |
---|---|---|---|
Henry Ji
CEO | Chief Executive Officer | 59 | 88-12-31 |
Shawn Sahebi
COO | Chief Operating Officer | - | - |
Mike A. Royal
CTO | Chief Tech/Sci/R&D Officer | 70 | 14-03-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kim D. Janda
BRD | Director/Board Member | 67 | 12-03-31 |
David Lemus
BRD | Director/Board Member | 61 | 17-09-30 |
Jaisim Shah
BRD | Director/Board Member | 63 | 13-09-10 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 0.015 | +3.45% | 208 012 |
24-04-29 | 0.0145 | +5.84% | 39,431 |
24-04-26 | 0.0137 | -31.50% | 54,423 |
24-04-25 | 0.02 | 0.00% | 62,408 |
24-04-24 | 0.02 | +33.33% | 97,454 |
Delayed Quote OTC Markets, April 29, 2024 at 03:59 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-88.26% | 7.88M | |
-2.63% | 102B | |
+1.62% | 96.29B | |
+1.60% | 22.18B | |
-16.67% | 21.2B | |
-8.68% | 18.31B | |
-38.74% | 17.38B | |
-13.21% | 16.36B | |
+5.41% | 13.97B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- SRNE Stock